The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in Beijing
NCT ID: NCT01236677
Last Updated: 2010-12-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1100 participants
OBSERVATIONAL
2010-08-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The project aim is to establish pneumonia pathogens network in Beijing and understand the pathogen spectrum distribution.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Community acquired pneumonia,age≥14 ys
Patients with community acquired pneumonia,age≥14 ys and less than one week after the onset of symptoms, without pregnancy,breast-feeding,HIV infection,recent 90-day hospitalized history and in nursing homes or rehabilitation hospitals
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age≥14 ys
3. New appear of cough or cough become severe
4. New infiltration showed by chest radiology(x-ray or CT)
5. Fever T\>37.8o C or \<35.6o C
6. White blood cell\>10,000/mm3 , left shift or leukopenia\<4000/ul）
Exclusion Criteria
2. Over one week after the onset of symptoms
3. HIV infection
4. Recent 90-day hospitalized history(length of stay greater than 2 days)
5. Live in nursing homes or rehabilitation hospitals
14 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Capital Medical University Affiliated Beijing Chaoyang Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chen Wang, Doctor
Role: STUDY_CHAIR
Capital Medical University affiliated Beijing Chaoyang Hospital, Beijing Respiratory Medicine Insititute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Capital Medical University affiliated Beijing Chaoyang Hospital, Beijing Respiratory Medicine Insititute
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Bin Cao, Doctor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
xfcrb123456
Identifier Type: -
Identifier Source: org_study_id